From Seekingalpha · SA Transcripts · · 30s
Coherus Oncology Shares Tagmokitug Trial Results
Coherus Oncology reveals interim tagmokitug clinical data for esophageal cancer treatment.
In brief
Coherus Oncology reveals interim tagmokitug clinical data for esophageal cancer treatment. Coherus Oncology presented interim clinical data showing tagmokitug's potential in esophageal cancer treatment. Originally reported by Seekingalpha.
Coherus Oncology
Coherus Oncology, Inc. (CHRS) discussed interim clinical data for tagmokitug in esophageal cancer.
Interim Clinical Data
The company shared interim results from tagmokitug trials targeting esophageal cancer treatment.
Clinical Presentation
Dennis Lanfear presented tagmokitug's potential in esophageal cancer with interim data.
What it means
Coherus Oncology presented interim clinical data showing tagmokitug's potential in esophageal cancer treatment.
